Suppl. 2 -S19 non-dominant MTLE, the smaller dominant HV at 2-3y period correlated with decline of verbal memory (p<0.05). Conclusions: Postoperative progression of non-epileptic hippocampal atrophy was found with significantly more pronounce in patients with older age at surgery and larger pre-operative non-epileptic hippocampus. After the epileptogenic hippocampus is resected, the remaining hippocampus alone might exhaust to maintain the memory, especially in elders.
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Survey of epilepsy and seizure awareness in Manitoba: an evaluation (SESAME) Background: Epilepsy/seizure awareness is improving across Canada. With the formation of a Comprehensive Epilepsy Program in Manitoba (including a new Pediatric Epilepsy Monitoring Unit), a provincial strategy has been proposed outlining a path towards improved access to epilepsy care. We now sought to qualify the current state of clinician knowledge and comfort towards diagnosis and management of this condition. Methods: A qualitative online survey, comprised of 36 short-answer questions, was delivered to primary care and specialist physicians in Manitoba. Results:108 subjects responded, across varying medical disciplines. 101 (93.5%) have previously managed epilepsy patients, and 87 (80.6%) have previously ordered an EEG. A total of 63 (59.4%) have referred to a neurologist, with a lower proportion (30, 28.3%) referring specifically to an epileptologist. 36 respondents (33.3%) have heard of the ILAE guidelines, with 43 (63.2%) reporting refractory epilepsy to be defined by the failure of 3 (or more) medications. 61 (56.5%) were unaware of invasive EEG techniques. Most (85, 78.7%) understood a role for surgery in treating epilepsy, with 12 (11.1%) unaware of surgical therapies beyond VNS. Conclusions: SESAME successfully identified strong awareness towards epilepsy, with small lapses in knowledge that will benefit from a formal provincial-wide educational curriculum.
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Mesial Temporal Sclerosis is a rare occurrence in Intractable Pediatric Temporal Lobe Epilepsies
Background: Temporal lobe epilepsy (TLE) accounts for approximately 20% of pediatric epilepsy cases. Of those, many are considered medically intractable and require surgical interventions. In this study, we hypothesized that mesial temporal sclerosis (MTS) was less common in patients who had undergone surgery for intractable pediatric TLE than in adult series. We further hypothesized that there was a radiological and pathological discordance in identifying the cause of pediatric TLE. Methods: We retrospectively reviewed the charts of pediatric patients with TLE who had undergone surgical treatments as part of the University of Alberta's Comprehensive Epilepsy Program between 1988 and 2018. Along with preoperative magnetic resonance imaging (MRI) reports, post-surgical pathology results and seizure outcomes were studied Results: Of the 83 pediatric patients who had undergone temporal lobe epilepsy surgery, 28% had tumors, 22% had dual pathologies, 18% had MTS, 11% had focal cortical dysplasia, and 22% had other pathologies. In addition, for 36% of these patients, discordance between their pre-surgical MRI reports and post-surgical pathology reports were found. Conclusions: This was one of the largest retrospective cohort studies of pediatric patients who had undergone surgery for intractable TLE. This study showed that tumors, and not MTS, were the most common pathology in surgical pediatric TLE .
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A novel de novo GABRA1 mutation linked to epileptic encephalopathy: pathophysiology and potential therapeutic options Background: Epileptic encephalopathy (EE) is a severe neurological disorder characterized by treatment-resistant seizures and poor neurodevelopmental outcomes. EE is associated with mutant genes, including those that encode for γ-aminobutyric acid type A (GABA A ) receptor subunits. We identified a novel de novo GABRA1 mutation in a patient with EE, characterized its impact on GABA A receptor function, and sought potential therapeutic options. Methods: We described the clinical and electrophysiological features of a patient with a novel de novo GABRA1 (R214C) mutation; performed THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES Suppl. 2 -S20 functional studies; and determined the effect of diazepam and insulin on wild type and mutant GABA A receptors. Results: The patient is a 10-year-old girl with EE, treatment-resistant seizures, intellectual disability and autism. Her GABRA1 (R214C) mutation dramatically decreased whole-cell GABA-evoked currents by reducing GABA A surface receptors, decreasing single channel open time, and altering channel kinetic properties. The combination of diazepam and insulin partially repaired these effects by enhancing channel activity and increasing the number of surface receptors, respectively. Conclusions: Diazepam and insulin partially mitigated a de novo GABRA1 (R214C) mutation's effects on GABA A receptor number and function. Given the risks of insulin use, pharmacological agents with similar mechanisms of action but fewer side effects, such as IGF-1, should be studied and considered for clinical application.
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Results of a Pilot feasibility study to develop reduce wait times strategy in the evaluation of children with new onset epilepsy
doi: 10.1017/cjn.2018.119
Background: The goal was to understand factors leading to prolonged wait times for neurological assessment of children with new onset seizures. A second objective was to develop an innovative approach to patient flow through and achieve a reduction in waiting times utilizing limited resources.
Methods:
1. Audit of the referrals, flow through, wait times 2. Identification of bottlenecks 3. Development of triaging strategy:
i. Suspected Febrile seizures and non-epileptic events; ii. Suspected benign and absence epilepsies; iii. Suspected other Focal epilepsies, generalized epilepsies, epilepsy under 2 years 4. Initiation of early telephone contact and support 5. Development of a ketogenic diet Results: Using a triaging strategy and focusing on timely access to investigations, wait times for clinic evaluations were shortened despite larger numbers of referrals (mean wait time reductions from 179 to 91 days). Limiting factors such increase in referral numbers, attrition in support staff, interfered with sustainability of reduced wait times achieved in the initial phase of the program. Conclusions: This pilot study highlights the effectiveness of an innovative triaging strategy and improvements in patient flow through in achieving the goals of reduction in wait times for clinical evaluation and timely investigations to improve care for children with new onset seizures. Insights into limitations of such strategies and factors determining sustainability are discussed.
